nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—PLA2G4A—Epirubicin—pancreatic cancer	0.282	0.375	CbGbCtD
Fluticasone Propionate—CYP3A7—Tamoxifen—pancreatic cancer	0.0479	0.0637	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0479	0.0637	CbGbCtD
Fluticasone Propionate—CYP3A7—Irinotecan—pancreatic cancer	0.0368	0.0489	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0368	0.0489	CbGbCtD
Fluticasone Propionate—CYP3A5—Tamoxifen—pancreatic cancer	0.036	0.0478	CbGbCtD
Fluticasone Propionate—CYP3A5—Erlotinib—pancreatic cancer	0.0306	0.0407	CbGbCtD
Fluticasone Propionate—CYP3A5—Irinotecan—pancreatic cancer	0.0276	0.0367	CbGbCtD
Fluticasone Propionate—CYP3A7—Docetaxel—pancreatic cancer	0.027	0.0359	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.027	0.0359	CbGbCtD
Fluticasone Propionate—CYP3A7—Sunitinib—pancreatic cancer	0.0269	0.0357	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0269	0.0357	CbGbCtD
Fluticasone Propionate—CYP3A5—Docetaxel—pancreatic cancer	0.0202	0.0269	CbGbCtD
Fluticasone Propionate—CYP3A5—Sunitinib—pancreatic cancer	0.0201	0.0268	CbGbCtD
Fluticasone Propionate—CYP3A4—Tamoxifen—pancreatic cancer	0.014	0.0186	CbGbCtD
Fluticasone Propionate—CYP3A4—Erlotinib—pancreatic cancer	0.0119	0.0159	CbGbCtD
Fluticasone Propionate—CYP3A4—Irinotecan—pancreatic cancer	0.0108	0.0143	CbGbCtD
Fluticasone Propionate—CYP3A4—Docetaxel—pancreatic cancer	0.00789	0.0105	CbGbCtD
Fluticasone Propionate—CYP3A4—Sunitinib—pancreatic cancer	0.00785	0.0104	CbGbCtD
Fluticasone Propionate—CYP3A4—Doxorubicin—pancreatic cancer	0.00588	0.00782	CbGbCtD
Fluticasone Propionate—Chest pain—Fluorouracil—pancreatic cancer	0.000242	0.00121	CcSEcCtD
Fluticasone Propionate—Infection—Irinotecan—pancreatic cancer	0.000241	0.0012	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000241	0.0012	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Epirubicin—pancreatic cancer	0.000241	0.0012	CcSEcCtD
Fluticasone Propionate—Pruritus—Erlotinib—pancreatic cancer	0.000241	0.0012	CcSEcCtD
Fluticasone Propionate—Discomfort—Fluorouracil—pancreatic cancer	0.000239	0.00119	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Irinotecan—pancreatic cancer	0.000238	0.00118	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Epirubicin—pancreatic cancer	0.000238	0.00118	CcSEcCtD
Fluticasone Propionate—Eczema—Doxorubicin—pancreatic cancer	0.000237	0.00118	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000236	0.00118	CcSEcCtD
Fluticasone Propionate—Oedema—Gemcitabine—pancreatic cancer	0.000236	0.00118	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Tamoxifen—pancreatic cancer	0.000235	0.00117	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000235	0.00117	CcSEcCtD
Fluticasone Propionate—Infection—Gemcitabine—pancreatic cancer	0.000235	0.00117	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Docetaxel—pancreatic cancer	0.000234	0.00117	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Sunitinib—pancreatic cancer	0.000233	0.00116	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Sunitinib—pancreatic cancer	0.000233	0.00116	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Erlotinib—pancreatic cancer	0.000233	0.00116	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000232	0.00116	CcSEcCtD
Fluticasone Propionate—Oedema—Fluorouracil—pancreatic cancer	0.000232	0.00116	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Docetaxel—pancreatic cancer	0.000232	0.00115	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000232	0.00115	CcSEcCtD
Fluticasone Propionate—Infection—Fluorouracil—pancreatic cancer	0.000231	0.00115	CcSEcCtD
Fluticasone Propionate—Skin disorder—Gemcitabine—pancreatic cancer	0.000229	0.00114	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000228	0.00113	CcSEcCtD
Fluticasone Propionate—Dizziness—Tamoxifen—pancreatic cancer	0.000227	0.00113	CcSEcCtD
Fluticasone Propionate—Tachycardia—Fluorouracil—pancreatic cancer	0.000227	0.00113	CcSEcCtD
Fluticasone Propionate—Dizziness—Erlotinib—pancreatic cancer	0.000225	0.00112	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Doxorubicin—pancreatic cancer	0.000223	0.00111	CcSEcCtD
Fluticasone Propionate—Face oedema—Epirubicin—pancreatic cancer	0.000222	0.00111	CcSEcCtD
Fluticasone Propionate—Eye disorder—Docetaxel—pancreatic cancer	0.00022	0.0011	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Doxorubicin—pancreatic cancer	0.00022	0.0011	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Docetaxel—pancreatic cancer	0.000219	0.00109	CcSEcCtD
Fluticasone Propionate—Vomiting—Tamoxifen—pancreatic cancer	0.000218	0.00109	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Sunitinib—pancreatic cancer	0.000217	0.00108	CcSEcCtD
Fluticasone Propionate—Rash—Tamoxifen—pancreatic cancer	0.000217	0.00108	CcSEcCtD
Fluticasone Propionate—Dermatitis—Tamoxifen—pancreatic cancer	0.000216	0.00108	CcSEcCtD
Fluticasone Propionate—Vomiting—Erlotinib—pancreatic cancer	0.000216	0.00108	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Irinotecan—pancreatic cancer	0.000216	0.00108	CcSEcCtD
Fluticasone Propionate—Headache—Tamoxifen—pancreatic cancer	0.000215	0.00107	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000215	0.00107	CcSEcCtD
Fluticasone Propionate—Rash—Erlotinib—pancreatic cancer	0.000214	0.00107	CcSEcCtD
Fluticasone Propionate—Dermatitis—Erlotinib—pancreatic cancer	0.000214	0.00107	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Docetaxel—pancreatic cancer	0.000213	0.00106	CcSEcCtD
Fluticasone Propionate—Headache—Erlotinib—pancreatic cancer	0.000213	0.00106	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000213	0.00106	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000212	0.00105	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Docetaxel—pancreatic cancer	0.000211	0.00105	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Gemcitabine—pancreatic cancer	0.000211	0.00105	CcSEcCtD
Fluticasone Propionate—Pruritus—Sunitinib—pancreatic cancer	0.000208	0.00104	CcSEcCtD
Fluticasone Propionate—Pain—Irinotecan—pancreatic cancer	0.000207	0.00103	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Fluorouracil—pancreatic cancer	0.000207	0.00103	CcSEcCtD
Fluticasone Propionate—Mental disorder—Docetaxel—pancreatic cancer	0.000207	0.00103	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000206	0.00102	CcSEcCtD
Fluticasone Propionate—Face oedema—Doxorubicin—pancreatic cancer	0.000205	0.00102	CcSEcCtD
Fluticasone Propionate—Erythema—Docetaxel—pancreatic cancer	0.000205	0.00102	CcSEcCtD
Fluticasone Propionate—Malnutrition—Docetaxel—pancreatic cancer	0.000205	0.00102	CcSEcCtD
Fluticasone Propionate—Nausea—Tamoxifen—pancreatic cancer	0.000204	0.00102	CcSEcCtD
Fluticasone Propionate—Pain—Gemcitabine—pancreatic cancer	0.000202	0.00101	CcSEcCtD
Fluticasone Propionate—Nausea—Erlotinib—pancreatic cancer	0.000202	0.00101	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Sunitinib—pancreatic cancer	0.000201	0.001	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Epirubicin—pancreatic cancer	0.0002	0.000997	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Irinotecan—pancreatic cancer	0.0002	0.000995	CcSEcCtD
Fluticasone Propionate—Asthma—Epirubicin—pancreatic cancer	0.000199	0.00099	CcSEcCtD
Fluticasone Propionate—Pain—Fluorouracil—pancreatic cancer	0.000199	0.000989	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000198	0.000988	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Docetaxel—pancreatic cancer	0.000197	0.000984	CcSEcCtD
Fluticasone Propionate—Dizziness—Sunitinib—pancreatic cancer	0.000195	0.00097	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000195	0.000969	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Irinotecan—pancreatic cancer	0.000192	0.000955	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Irinotecan—pancreatic cancer	0.000192	0.000955	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000191	0.000953	CcSEcCtD
Fluticasone Propionate—Bronchitis—Epirubicin—pancreatic cancer	0.000191	0.000952	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.00019	0.000948	CcSEcCtD
Fluticasone Propionate—Vomiting—Sunitinib—pancreatic cancer	0.000187	0.000932	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Gemcitabine—pancreatic cancer	0.000187	0.00093	CcSEcCtD
Fluticasone Propionate—Rash—Sunitinib—pancreatic cancer	0.000186	0.000924	CcSEcCtD
Fluticasone Propionate—Dermatitis—Sunitinib—pancreatic cancer	0.000185	0.000924	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Doxorubicin—pancreatic cancer	0.000185	0.000922	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000185	0.00092	CcSEcCtD
Fluticasone Propionate—Urticaria—Fluorouracil—pancreatic cancer	0.000184	0.000919	CcSEcCtD
Fluticasone Propionate—Headache—Sunitinib—pancreatic cancer	0.000184	0.000919	CcSEcCtD
Fluticasone Propionate—Asthma—Doxorubicin—pancreatic cancer	0.000184	0.000916	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Fluorouracil—pancreatic cancer	0.000184	0.000914	CcSEcCtD
Fluticasone Propionate—Palpitations—Docetaxel—pancreatic cancer	0.000181	0.000904	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000179	0.000893	CcSEcCtD
Fluticasone Propionate—Cough—Docetaxel—pancreatic cancer	0.000179	0.000893	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Irinotecan—pancreatic cancer	0.000179	0.00089	CcSEcCtD
Fluticasone Propionate—Pneumonia—Epirubicin—pancreatic cancer	0.000178	0.000888	CcSEcCtD
Fluticasone Propionate—Hypertension—Docetaxel—pancreatic cancer	0.000177	0.000883	CcSEcCtD
Fluticasone Propionate—Infestation—Epirubicin—pancreatic cancer	0.000177	0.000883	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Epirubicin—pancreatic cancer	0.000177	0.000883	CcSEcCtD
Fluticasone Propionate—Bronchitis—Doxorubicin—pancreatic cancer	0.000177	0.000881	CcSEcCtD
Fluticasone Propionate—Chest pain—Docetaxel—pancreatic cancer	0.000175	0.000871	CcSEcCtD
Fluticasone Propionate—Arthralgia—Docetaxel—pancreatic cancer	0.000175	0.000871	CcSEcCtD
Fluticasone Propionate—Nausea—Sunitinib—pancreatic cancer	0.000175	0.000871	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000174	0.000865	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Epirubicin—pancreatic cancer	0.000172	0.000858	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000171	0.000852	CcSEcCtD
Fluticasone Propionate—Dry mouth—Docetaxel—pancreatic cancer	0.000171	0.000852	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000171	0.000852	CcSEcCtD
Fluticasone Propionate—Oedema—Docetaxel—pancreatic cancer	0.000168	0.000835	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000168	0.000835	CcSEcCtD
Fluticasone Propionate—Epistaxis—Epirubicin—pancreatic cancer	0.000167	0.000833	CcSEcCtD
Fluticasone Propionate—Pruritus—Gemcitabine—pancreatic cancer	0.000167	0.000832	CcSEcCtD
Fluticasone Propionate—Infection—Docetaxel—pancreatic cancer	0.000166	0.000829	CcSEcCtD
Fluticasone Propionate—Sinusitis—Epirubicin—pancreatic cancer	0.000166	0.000828	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000166	0.000827	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Irinotecan—pancreatic cancer	0.000166	0.000826	CcSEcCtD
Fluticasone Propionate—Pneumonia—Doxorubicin—pancreatic cancer	0.000165	0.000822	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Docetaxel—pancreatic cancer	0.000164	0.000819	CcSEcCtD
Fluticasone Propionate—Pruritus—Fluorouracil—pancreatic cancer	0.000164	0.000818	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Doxorubicin—pancreatic cancer	0.000164	0.000817	CcSEcCtD
Fluticasone Propionate—Infestation—Doxorubicin—pancreatic cancer	0.000164	0.000817	CcSEcCtD
Fluticasone Propionate—Tachycardia—Docetaxel—pancreatic cancer	0.000164	0.000815	CcSEcCtD
Fluticasone Propionate—Skin disorder—Docetaxel—pancreatic cancer	0.000163	0.000811	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000162	0.000805	CcSEcCtD
Fluticasone Propionate—Dizziness—Irinotecan—pancreatic cancer	0.00016	0.000799	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000159	0.000794	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000159	0.000791	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000158	0.000789	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Epirubicin—pancreatic cancer	0.000158	0.000787	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000156	0.000779	CcSEcCtD
Fluticasone Propionate—Epistaxis—Doxorubicin—pancreatic cancer	0.000155	0.000771	CcSEcCtD
Fluticasone Propionate—Vomiting—Irinotecan—pancreatic cancer	0.000154	0.000768	CcSEcCtD
Fluticasone Propionate—Sinusitis—Doxorubicin—pancreatic cancer	0.000154	0.000766	CcSEcCtD
Fluticasone Propionate—Dizziness—Fluorouracil—pancreatic cancer	0.000154	0.000765	CcSEcCtD
Fluticasone Propionate—Rash—Irinotecan—pancreatic cancer	0.000153	0.000762	CcSEcCtD
Fluticasone Propionate—Dermatitis—Irinotecan—pancreatic cancer	0.000153	0.000761	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000153	0.000761	CcSEcCtD
Fluticasone Propionate—Headache—Irinotecan—pancreatic cancer	0.000152	0.000757	CcSEcCtD
Fluticasone Propionate—Vomiting—Gemcitabine—pancreatic cancer	0.00015	0.000748	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Docetaxel—pancreatic cancer	0.000149	0.000744	CcSEcCtD
Fluticasone Propionate—Rash—Gemcitabine—pancreatic cancer	0.000149	0.000742	CcSEcCtD
Fluticasone Propionate—Dermatitis—Gemcitabine—pancreatic cancer	0.000149	0.000741	CcSEcCtD
Fluticasone Propionate—Eye disorder—Epirubicin—pancreatic cancer	0.000149	0.000741	CcSEcCtD
Fluticasone Propionate—Headache—Gemcitabine—pancreatic cancer	0.000148	0.000737	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Epirubicin—pancreatic cancer	0.000148	0.000736	CcSEcCtD
Fluticasone Propionate—Vomiting—Fluorouracil—pancreatic cancer	0.000148	0.000735	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000146	0.00073	CcSEcCtD
Fluticasone Propionate—Rash—Fluorouracil—pancreatic cancer	0.000146	0.000729	CcSEcCtD
Fluticasone Propionate—Dermatitis—Fluorouracil—pancreatic cancer	0.000146	0.000729	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Doxorubicin—pancreatic cancer	0.000146	0.000728	CcSEcCtD
Fluticasone Propionate—Headache—Fluorouracil—pancreatic cancer	0.000145	0.000725	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000145	0.000721	CcSEcCtD
Fluticasone Propionate—Nausea—Irinotecan—pancreatic cancer	0.000144	0.000717	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Epirubicin—pancreatic cancer	0.000144	0.000716	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000143	0.000714	CcSEcCtD
Fluticasone Propionate—Pain—Docetaxel—pancreatic cancer	0.000143	0.000714	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Epirubicin—pancreatic cancer	0.000142	0.000708	CcSEcCtD
Fluticasone Propionate—Nausea—Gemcitabine—pancreatic cancer	0.00014	0.000699	CcSEcCtD
Fluticasone Propionate—Mental disorder—Epirubicin—pancreatic cancer	0.000139	0.000694	CcSEcCtD
Fluticasone Propionate—Erythema—Epirubicin—pancreatic cancer	0.000139	0.00069	CcSEcCtD
Fluticasone Propionate—Malnutrition—Epirubicin—pancreatic cancer	0.000139	0.00069	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Docetaxel—pancreatic cancer	0.000138	0.000688	CcSEcCtD
Fluticasone Propionate—Nausea—Fluorouracil—pancreatic cancer	0.000138	0.000687	CcSEcCtD
Fluticasone Propionate—Eye disorder—Doxorubicin—pancreatic cancer	0.000138	0.000685	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000137	0.000683	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000137	0.000681	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Epirubicin—pancreatic cancer	0.000133	0.000663	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Doxorubicin—pancreatic cancer	0.000133	0.000662	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000133	0.000661	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Docetaxel—pancreatic cancer	0.000132	0.00066	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Docetaxel—pancreatic cancer	0.000132	0.00066	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Doxorubicin—pancreatic cancer	0.000132	0.000655	CcSEcCtD
Fluticasone Propionate—Vision blurred—Epirubicin—pancreatic cancer	0.000131	0.00065	CcSEcCtD
Fluticasone Propionate—Mental disorder—Doxorubicin—pancreatic cancer	0.000129	0.000643	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000129	0.00064	CcSEcCtD
Fluticasone Propionate—Erythema—Doxorubicin—pancreatic cancer	0.000128	0.000638	CcSEcCtD
Fluticasone Propionate—Malnutrition—Doxorubicin—pancreatic cancer	0.000128	0.000638	CcSEcCtD
Fluticasone Propionate—Agitation—Epirubicin—pancreatic cancer	0.000127	0.000634	CcSEcCtD
Fluticasone Propionate—Malaise—Epirubicin—pancreatic cancer	0.000125	0.000622	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000123	0.000615	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Doxorubicin—pancreatic cancer	0.000123	0.000614	CcSEcCtD
Fluticasone Propionate—Palpitations—Epirubicin—pancreatic cancer	0.000122	0.00061	CcSEcCtD
Fluticasone Propionate—Cough—Epirubicin—pancreatic cancer	0.000121	0.000602	CcSEcCtD
Fluticasone Propionate—Vision blurred—Doxorubicin—pancreatic cancer	0.000121	0.000602	CcSEcCtD
Fluticasone Propionate—Hypertension—Epirubicin—pancreatic cancer	0.00012	0.000596	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000119	0.000592	CcSEcCtD
Fluticasone Propionate—Pruritus—Docetaxel—pancreatic cancer	0.000119	0.000591	CcSEcCtD
Fluticasone Propionate—Chest pain—Epirubicin—pancreatic cancer	0.000118	0.000587	CcSEcCtD
Fluticasone Propionate—Arthralgia—Epirubicin—pancreatic cancer	0.000118	0.000587	CcSEcCtD
Fluticasone Propionate—Agitation—Doxorubicin—pancreatic cancer	0.000118	0.000587	CcSEcCtD
Fluticasone Propionate—Anxiety—Epirubicin—pancreatic cancer	0.000118	0.000585	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000117	0.000583	CcSEcCtD
Fluticasone Propionate—Discomfort—Epirubicin—pancreatic cancer	0.000117	0.00058	CcSEcCtD
Fluticasone Propionate—Malaise—Doxorubicin—pancreatic cancer	0.000116	0.000576	CcSEcCtD
Fluticasone Propionate—Dry mouth—Epirubicin—pancreatic cancer	0.000115	0.000575	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Docetaxel—pancreatic cancer	0.000115	0.000571	CcSEcCtD
Fluticasone Propionate—Palpitations—Doxorubicin—pancreatic cancer	0.000113	0.000564	CcSEcCtD
Fluticasone Propionate—Oedema—Epirubicin—pancreatic cancer	0.000113	0.000563	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000113	0.000563	CcSEcCtD
Fluticasone Propionate—Infection—Epirubicin—pancreatic cancer	0.000112	0.000559	CcSEcCtD
Fluticasone Propionate—Cough—Doxorubicin—pancreatic cancer	0.000112	0.000557	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Epirubicin—pancreatic cancer	0.000111	0.000552	CcSEcCtD
Fluticasone Propionate—Dizziness—Docetaxel—pancreatic cancer	0.000111	0.000552	CcSEcCtD
Fluticasone Propionate—Hypertension—Doxorubicin—pancreatic cancer	0.000111	0.000551	CcSEcCtD
Fluticasone Propionate—Tachycardia—Epirubicin—pancreatic cancer	0.00011	0.00055	CcSEcCtD
Fluticasone Propionate—Skin disorder—Epirubicin—pancreatic cancer	0.00011	0.000547	CcSEcCtD
Fluticasone Propionate—Chest pain—Doxorubicin—pancreatic cancer	0.000109	0.000544	CcSEcCtD
Fluticasone Propionate—Arthralgia—Doxorubicin—pancreatic cancer	0.000109	0.000544	CcSEcCtD
Fluticasone Propionate—Anxiety—Doxorubicin—pancreatic cancer	0.000109	0.000542	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000108	0.00054	CcSEcCtD
Fluticasone Propionate—Discomfort—Doxorubicin—pancreatic cancer	0.000108	0.000537	CcSEcCtD
Fluticasone Propionate—Dry mouth—Doxorubicin—pancreatic cancer	0.000107	0.000532	CcSEcCtD
Fluticasone Propionate—Vomiting—Docetaxel—pancreatic cancer	0.000107	0.000531	CcSEcCtD
Fluticasone Propionate—Rash—Docetaxel—pancreatic cancer	0.000106	0.000526	CcSEcCtD
Fluticasone Propionate—Dermatitis—Docetaxel—pancreatic cancer	0.000106	0.000526	CcSEcCtD
Fluticasone Propionate—Headache—Docetaxel—pancreatic cancer	0.000105	0.000523	CcSEcCtD
Fluticasone Propionate—Oedema—Doxorubicin—pancreatic cancer	0.000105	0.000521	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000105	0.000521	CcSEcCtD
Fluticasone Propionate—Infection—Doxorubicin—pancreatic cancer	0.000104	0.000518	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000103	0.000513	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000103	0.000511	CcSEcCtD
Fluticasone Propionate—Tachycardia—Doxorubicin—pancreatic cancer	0.000102	0.000509	CcSEcCtD
Fluticasone Propionate—Skin disorder—Doxorubicin—pancreatic cancer	0.000102	0.000506	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Epirubicin—pancreatic cancer	0.000101	0.000502	CcSEcCtD
Fluticasone Propionate—Nausea—Docetaxel—pancreatic cancer	9.95e-05	0.000496	CcSEcCtD
Fluticasone Propionate—Pain—Epirubicin—pancreatic cancer	9.67e-05	0.000482	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	9.53e-05	0.000475	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Doxorubicin—pancreatic cancer	9.32e-05	0.000465	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Epirubicin—pancreatic cancer	9.32e-05	0.000464	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Epirubicin—pancreatic cancer	9.24e-05	0.00046	CcSEcCtD
Fluticasone Propionate—Urticaria—Epirubicin—pancreatic cancer	8.98e-05	0.000447	CcSEcCtD
Fluticasone Propionate—Pain—Doxorubicin—pancreatic cancer	8.94e-05	0.000446	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Epirubicin—pancreatic cancer	8.94e-05	0.000445	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Epirubicin—pancreatic cancer	8.94e-05	0.000445	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Doxorubicin—pancreatic cancer	8.62e-05	0.000429	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	8.55e-05	0.000426	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Epirubicin—pancreatic cancer	8.33e-05	0.000415	CcSEcCtD
Fluticasone Propionate—Urticaria—Doxorubicin—pancreatic cancer	8.31e-05	0.000414	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Doxorubicin—pancreatic cancer	8.27e-05	0.000412	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Doxorubicin—pancreatic cancer	8.27e-05	0.000412	CcSEcCtD
Fluticasone Propionate—Pruritus—Epirubicin—pancreatic cancer	8e-05	0.000398	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Epirubicin—pancreatic cancer	7.73e-05	0.000385	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Doxorubicin—pancreatic cancer	7.71e-05	0.000384	CcSEcCtD
Fluticasone Propionate—Dizziness—Epirubicin—pancreatic cancer	7.47e-05	0.000372	CcSEcCtD
Fluticasone Propionate—Pruritus—Doxorubicin—pancreatic cancer	7.4e-05	0.000369	CcSEcCtD
Fluticasone Propionate—Vomiting—Epirubicin—pancreatic cancer	7.19e-05	0.000358	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Doxorubicin—pancreatic cancer	7.16e-05	0.000357	CcSEcCtD
Fluticasone Propionate—Rash—Epirubicin—pancreatic cancer	7.13e-05	0.000355	CcSEcCtD
Fluticasone Propionate—Dermatitis—Epirubicin—pancreatic cancer	7.12e-05	0.000355	CcSEcCtD
Fluticasone Propionate—Headache—Epirubicin—pancreatic cancer	7.08e-05	0.000353	CcSEcCtD
Fluticasone Propionate—Dizziness—Doxorubicin—pancreatic cancer	6.92e-05	0.000345	CcSEcCtD
Fluticasone Propionate—Nausea—Epirubicin—pancreatic cancer	6.71e-05	0.000334	CcSEcCtD
Fluticasone Propionate—Vomiting—Doxorubicin—pancreatic cancer	6.65e-05	0.000331	CcSEcCtD
Fluticasone Propionate—Rash—Doxorubicin—pancreatic cancer	6.59e-05	0.000329	CcSEcCtD
Fluticasone Propionate—Dermatitis—Doxorubicin—pancreatic cancer	6.59e-05	0.000328	CcSEcCtD
Fluticasone Propionate—Headache—Doxorubicin—pancreatic cancer	6.55e-05	0.000326	CcSEcCtD
Fluticasone Propionate—Nausea—Doxorubicin—pancreatic cancer	6.21e-05	0.00031	CcSEcCtD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCKBR—pancreatic cancer	4.24e-05	0.000898	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SCT—pancreatic cancer	4.23e-05	0.000896	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HEY1—pancreatic cancer	4.23e-05	0.000896	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	4.23e-05	0.000896	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—SST—pancreatic cancer	4.23e-05	0.000896	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Adipogenesis—TNF—pancreatic cancer	4.19e-05	0.000889	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—NOTCH1—pancreatic cancer	4.18e-05	0.000885	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	4.15e-05	0.00088	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—SMAD4—pancreatic cancer	4.14e-05	0.000878	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCK—pancreatic cancer	4.03e-05	0.000855	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GLI1—pancreatic cancer	3.98e-05	0.000844	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—DTX4—pancreatic cancer	3.98e-05	0.000844	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	3.97e-05	0.000841	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—PPARG—pancreatic cancer	3.94e-05	0.000836	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.93e-05	0.000833	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CNR2—pancreatic cancer	3.93e-05	0.000833	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GLP1R—pancreatic cancer	3.93e-05	0.000833	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CNR1—pancreatic cancer	3.9e-05	0.000827	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CG—pancreatic cancer	3.9e-05	0.000826	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NRP1—pancreatic cancer	3.88e-05	0.000822	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PPP2R5B—pancreatic cancer	3.88e-05	0.000822	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCKAR—pancreatic cancer	3.87e-05	0.00082	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—EGF—pancreatic cancer	3.85e-05	0.000817	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GLP1R—pancreatic cancer	3.84e-05	0.000814	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	3.84e-05	0.000814	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ARG2—pancreatic cancer	3.8e-05	0.000805	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—DPYD—pancreatic cancer	3.78e-05	0.000801	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—GCG—pancreatic cancer	3.77e-05	0.000799	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—JAG2—pancreatic cancer	3.75e-05	0.000795	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HEY2—pancreatic cancer	3.73e-05	0.000791	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MEN1—pancreatic cancer	3.7e-05	0.000783	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GAST—pancreatic cancer	3.64e-05	0.000772	CbGpPWpGaD
Fluticasone Propionate—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	3.62e-05	0.000768	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AGTR1—pancreatic cancer	3.59e-05	0.000762	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—SLC2A2—pancreatic cancer	3.59e-05	0.00076	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.55e-05	0.000752	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	3.53e-05	0.000749	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SHH—pancreatic cancer	3.53e-05	0.000747	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOTCH4—pancreatic cancer	3.5e-05	0.000743	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IAPP—pancreatic cancer	3.48e-05	0.000738	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SCT—pancreatic cancer	3.45e-05	0.000732	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HEY1—pancreatic cancer	3.45e-05	0.000732	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—SMAD4—pancreatic cancer	3.45e-05	0.000732	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CD—pancreatic cancer	3.43e-05	0.000726	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.42e-05	0.000726	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTHLH—pancreatic cancer	3.34e-05	0.000709	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTCH1—pancreatic cancer	3.34e-05	0.000709	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TYMP—pancreatic cancer	3.32e-05	0.000704	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCK—pancreatic cancer	3.3e-05	0.000699	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MEN1—pancreatic cancer	3.29e-05	0.000696	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.24e-05	0.000687	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CNR2—pancreatic cancer	3.21e-05	0.000681	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GLP1R—pancreatic cancer	3.21e-05	0.000681	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PRSS1—pancreatic cancer	3.17e-05	0.000671	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCKAR—pancreatic cancer	3.16e-05	0.00067	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.12e-05	0.000661	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH4—pancreatic cancer	3.11e-05	0.00066	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—JAG2—pancreatic cancer	3.06e-05	0.000649	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SST—pancreatic cancer	3.06e-05	0.000648	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	3.05e-05	0.000647	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MEN1—pancreatic cancer	3.02e-05	0.00064	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—JAG1—pancreatic cancer	2.99e-05	0.000634	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CB—pancreatic cancer	2.99e-05	0.000633	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOTCH3—pancreatic cancer	2.98e-05	0.000631	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—HSPA1B—pancreatic cancer	2.97e-05	0.00063	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	2.89e-05	0.000612	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—PPARG—pancreatic cancer	2.88e-05	0.000611	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SHH—pancreatic cancer	2.88e-05	0.000611	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH4—pancreatic cancer	2.86e-05	0.000607	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IAPP—pancreatic cancer	2.84e-05	0.000603	CbGpPWpGaD
Fluticasone Propionate—PGR—Generic Transcription Pathway—MYC—pancreatic cancer	2.84e-05	0.000603	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CNR1—pancreatic cancer	2.82e-05	0.000598	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CD44—pancreatic cancer	2.78e-05	0.000589	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ARG2—pancreatic cancer	2.75e-05	0.000582	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTHLH—pancreatic cancer	2.73e-05	0.000579	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTCH1—pancreatic cancer	2.73e-05	0.000579	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—GCG—pancreatic cancer	2.72e-05	0.000578	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.72e-05	0.000576	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—EZH2—pancreatic cancer	2.71e-05	0.000574	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.69e-05	0.000571	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GLP1R—pancreatic cancer	2.68e-05	0.000567	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—GCG—pancreatic cancer	2.66e-05	0.000564	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	2.65e-05	0.000561	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—DPYD—pancreatic cancer	2.63e-05	0.000558	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AGTR1—pancreatic cancer	2.6e-05	0.000551	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STK11—pancreatic cancer	2.56e-05	0.000543	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—NOTCH1—pancreatic cancer	2.54e-05	0.000539	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	2.51e-05	0.000532	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—STK11—pancreatic cancer	2.5e-05	0.000531	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SLC2A2—pancreatic cancer	2.5e-05	0.00053	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SST—pancreatic cancer	2.5e-05	0.000529	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—JAG1—pancreatic cancer	2.44e-05	0.000518	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH3—pancreatic cancer	2.43e-05	0.000516	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—PPARG—pancreatic cancer	2.4e-05	0.000509	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TYMP—pancreatic cancer	2.4e-05	0.000509	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—SRC—pancreatic cancer	2.39e-05	0.000507	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.35e-05	0.000498	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—VEGFA—pancreatic cancer	2.33e-05	0.000494	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CNR1—pancreatic cancer	2.3e-05	0.000489	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—NRAS—pancreatic cancer	2.3e-05	0.000488	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—MYC—pancreatic cancer	2.25e-05	0.000476	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SMAD4—pancreatic cancer	2.24e-05	0.000476	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CG—pancreatic cancer	2.24e-05	0.000474	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GCG—pancreatic cancer	2.23e-05	0.000472	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HES1—pancreatic cancer	2.19e-05	0.000464	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—TYMS—pancreatic cancer	2.15e-05	0.000456	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TGFB1—pancreatic cancer	2.14e-05	0.000453	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AGTR1—pancreatic cancer	2.12e-05	0.00045	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STK11—pancreatic cancer	2.09e-05	0.000444	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SMAD4—pancreatic cancer	1.99e-05	0.000423	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—KRAS—pancreatic cancer	1.98e-05	0.00042	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CD—pancreatic cancer	1.97e-05	0.000417	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CD44—pancreatic cancer	1.94e-05	0.00041	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GLP1R—pancreatic cancer	1.93e-05	0.00041	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TERT—pancreatic cancer	1.92e-05	0.000407	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—DPYD—pancreatic cancer	1.9e-05	0.000403	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GCG—pancreatic cancer	1.86e-05	0.000393	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HIF1A—pancreatic cancer	1.84e-05	0.000389	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SMAD4—pancreatic cancer	1.83e-05	0.000389	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TSC2—pancreatic cancer	1.83e-05	0.000388	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—PIK3CA—pancreatic cancer	1.82e-05	0.000386	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	1.81e-05	0.000383	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APOE—pancreatic cancer	1.79e-05	0.00038	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HES1—pancreatic cancer	1.79e-05	0.000379	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—TP53—pancreatic cancer	1.76e-05	0.000373	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KDR—pancreatic cancer	1.76e-05	0.000372	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—APOE—pancreatic cancer	1.75e-05	0.000371	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—STK11—pancreatic cancer	1.74e-05	0.00037	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CB—pancreatic cancer	1.71e-05	0.000363	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—HRAS—pancreatic cancer	1.68e-05	0.000357	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NFKBIA—pancreatic cancer	1.67e-05	0.000354	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.66e-05	0.000351	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOTCH1—pancreatic cancer	1.65e-05	0.000351	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—CXCL8—pancreatic cancer	1.65e-05	0.000349	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	1.64e-05	0.000348	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CG—pancreatic cancer	1.62e-05	0.000343	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGF—pancreatic cancer	1.6e-05	0.000339	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CG—pancreatic cancer	1.58e-05	0.000335	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TERT—pancreatic cancer	1.57e-05	0.000332	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—pancreatic cancer	1.56e-05	0.00033	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PPARG—pancreatic cancer	1.53e-05	0.000323	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—TYMS—pancreatic cancer	1.5e-05	0.000318	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HIF1A—pancreatic cancer	1.5e-05	0.000318	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TSC2—pancreatic cancer	1.5e-05	0.000317	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—pancreatic cancer	1.49e-05	0.000315	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.47e-05	0.000312	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	1.47e-05	0.000312	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APOE—pancreatic cancer	1.46e-05	0.00031	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KDR—pancreatic cancer	1.43e-05	0.000304	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CD—pancreatic cancer	1.42e-05	0.000301	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CD44—pancreatic cancer	1.4e-05	0.000296	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CD—pancreatic cancer	1.39e-05	0.000294	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PPARG—pancreatic cancer	1.39e-05	0.000294	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—MYC—pancreatic cancer	1.37e-05	0.00029	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NFKBIA—pancreatic cancer	1.36e-05	0.000289	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOTCH1—pancreatic cancer	1.35e-05	0.000286	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GCG—pancreatic cancer	1.34e-05	0.000284	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CG—pancreatic cancer	1.32e-05	0.00028	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—NRAS—pancreatic cancer	1.32e-05	0.00028	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGF—pancreatic cancer	1.31e-05	0.000277	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.28e-05	0.000271	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—STK11—pancreatic cancer	1.26e-05	0.000267	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CB—pancreatic cancer	1.24e-05	0.000263	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—APOE—pancreatic cancer	1.22e-05	0.000259	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CB—pancreatic cancer	1.21e-05	0.000257	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EGFR—pancreatic cancer	1.2e-05	0.000255	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—pancreatic cancer	1.2e-05	0.000254	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CXCL8—pancreatic cancer	1.19e-05	0.000252	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CD—pancreatic cancer	1.16e-05	0.000246	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CASP3—pancreatic cancer	1.14e-05	0.000242	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—KRAS—pancreatic cancer	1.14e-05	0.000241	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.12e-05	0.000237	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCND1—pancreatic cancer	1.11e-05	0.000235	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	1.1e-05	0.000233	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CTNNB1—pancreatic cancer	1.1e-05	0.000233	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—TYMS—pancreatic cancer	1.08e-05	0.00023	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MMP9—pancreatic cancer	1.08e-05	0.000228	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PTEN—pancreatic cancer	1.07e-05	0.000227	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARG—pancreatic cancer	1.06e-05	0.000225	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTEN—pancreatic cancer	1.05e-05	0.000222	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.04e-05	0.000221	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CB—pancreatic cancer	1.01e-05	0.000215	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SRC—pancreatic cancer	9.93e-06	0.000211	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CXCL8—pancreatic cancer	9.73e-06	0.000206	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	9.68e-06	0.000205	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—pancreatic cancer	9.67e-06	0.000205	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—HRAS—pancreatic cancer	9.67e-06	0.000205	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—STAT3—pancreatic cancer	9.58e-06	0.000203	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NRAS—pancreatic cancer	9.55e-06	0.000203	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—pancreatic cancer	9.49e-06	0.000201	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CASP3—pancreatic cancer	9.31e-06	0.000197	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCND1—pancreatic cancer	9.06e-06	0.000192	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GLP1R—pancreatic cancer	8.99e-06	0.000191	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CTNNB1—pancreatic cancer	8.98e-06	0.00019	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MYC—pancreatic cancer	8.9e-06	0.000189	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TGFB1—pancreatic cancer	8.88e-06	0.000188	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—DPYD—pancreatic cancer	8.85e-06	0.000188	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOE—pancreatic cancer	8.82e-06	0.000187	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP9—pancreatic cancer	8.8e-06	0.000187	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PTEN—pancreatic cancer	8.75e-06	0.000185	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGFR—pancreatic cancer	8.71e-06	0.000185	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—pancreatic cancer	8.54e-06	0.000181	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	8.44e-06	0.000179	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	8.4e-06	0.000178	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—pancreatic cancer	8.36e-06	0.000177	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—KRAS—pancreatic cancer	8.22e-06	0.000174	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SRC—pancreatic cancer	8.11e-06	0.000172	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	7.96e-06	0.000169	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—MYC—pancreatic cancer	7.91e-06	0.000168	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—pancreatic cancer	7.9e-06	0.000168	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—STAT3—pancreatic cancer	7.82e-06	0.000166	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NRAS—pancreatic cancer	7.81e-06	0.000165	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARG—pancreatic cancer	7.68e-06	0.000163	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3CA—pancreatic cancer	7.56e-06	0.00016	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3CA—pancreatic cancer	7.38e-06	0.000156	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TP53—pancreatic cancer	7.31e-06	0.000155	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTEN—pancreatic cancer	7.29e-06	0.000155	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MYC—pancreatic cancer	7.27e-06	0.000154	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFB1—pancreatic cancer	7.25e-06	0.000154	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGFR—pancreatic cancer	7.11e-06	0.000151	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	7e-06	0.000148	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HRAS—pancreatic cancer	6.99e-06	0.000148	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—KRAS—pancreatic cancer	6.72e-06	0.000142	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CD44—pancreatic cancer	6.5e-06	0.000138	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GCG—pancreatic cancer	6.23e-06	0.000132	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3CA—pancreatic cancer	6.17e-06	0.000131	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—pancreatic cancer	6.17e-06	0.000131	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	6.1e-06	0.000129	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—pancreatic cancer	6.04e-06	0.000128	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—pancreatic cancer	6.03e-06	0.000128	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TP53—pancreatic cancer	5.97e-06	0.000127	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—STK11—pancreatic cancer	5.86e-06	0.000124	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HRAS—pancreatic cancer	5.71e-06	0.000121	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—pancreatic cancer	5.49e-06	0.000116	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTEN—pancreatic cancer	5.27e-06	0.000112	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	5.14e-06	0.000109	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—TYMS—pancreatic cancer	5.04e-06	0.000107	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—pancreatic cancer	5.04e-06	0.000107	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—pancreatic cancer	4.2e-06	8.91e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOE—pancreatic cancer	4.1e-06	8.69e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	3.72e-06	7.88e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	3.7e-06	7.84e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARG—pancreatic cancer	3.57e-06	7.57e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.25e-06	6.9e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—pancreatic cancer	3.04e-06	6.44e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	2.84e-06	6.01e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—pancreatic cancer	2.81e-06	5.96e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.45e-06	5.19e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.73e-06	3.66e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.41e-06	2.99e-05	CbGpPWpGaD
